Electrolyte disruption in drug-resistant tuberculosis: Managing risks for improved treatment outcomes

---

Editorial

Author Details : Sankalp Yadav*

Volume : 9, Issue : 2, Year : 2024

Article Page : 49-50

https://doi.org/10.18231/j.ijirm.2024.010

Suggest article by email

Get Permission

---

Abstract

This editorial sheds light on the critical issue of electrolyte imbalance in drug-resistant tuberculosis (TB), a significant challenge exacerbated by the prolonged and intensive treatment regimens required for multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB strains. The use of second-line drugs, such as fluoroquinolones and aminoglycosides, necessary in these cases, often disrupts electrolyte homeostasis, leading to complications like hypokalemia and hypomagnesaemia. These disturbances can pose serious risks to patients, including cardiac arrhythmias and renal dysfunction. Beyond medication effects, TB itself induces systemic inflammation and metabolic alterations, further complicating electrolyte balance. Effective management necessitates vigilant monitoring of electrolyte levels throughout treatment, coupled with renal function assessments and nutritional support.
 

Keywords: Drug-resistant tuberculosis, Electrolyte imbalance, Second-line drugs, Treatment complications, Patient management

How to cite : Yadav S, Electrolyte disruption in drug-resistant tuberculosis: Managing risks for improved treatment outcomes. IP Indian J Immunol Respir Med 2024;9(2):49-50

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.